• XELL Deutschland
  • XELL English
  • XELL China

Maximizing process yields: Trust Xell with our ideal combination of R&D services!

High-performance cell culture media for the production of monoclonal antibodies – and vaccines or viral vectors for gene therapy applications especially – are more relevant than ever. One efficient approach to increase process yields is to select the most suitable medium – or even better, to utilize a completely customized medium. By leveraging Xell’s long-standing expertise in customized medium development, in combination with our related process development services, there is nothing to stop you from maximizing your process yields. Take a look at how we can advance your project from the initial inquiry and onwards:

Xell RnD Project Structure for Medium and Process Development

Your journey from initial request to maximized process performance.

Find out more about our long-standing experience in medium and feed screening, cell culture media and feed development and process optimization.